By Associate Professor James Edward Thompson

Journal articles

Mak G; Chew K; Wood D; Thompson J, 2024, 'Primary squamous cell carcinoma of the prostate', BMJ case reports, 17, http://dx.doi.org/10.1136/bcr-2024-262520

Gibson D; Shanmugasundaram R; McClintock G; Pham C; Hutton A; Ahmadi N; Arianayagam M; Elmes M; Thanigasalam R; Doeuk N; Papadopoulos B; Ngo T; Rathore P; Rasiah K; Thompson J; Aslan P; Treacy PJ; Leslie S, 2024, 'Robotic-Assisted Bladder Diverticulectomy: Indications, Technique, and Outcomes—A Case Series', Journal of Endourology, 38, pp. 1013 - 1020, http://dx.doi.org/10.1089/end.2024.0209

Emmett L; Papa N; Hope TA; Fendler W; Calais J; Burger I; Eiber M; Barbato F; Moon D; Counter W; John N; Xue A; Franklin A; Thompson J; Rasiah K; Frydenberg M; Yaxley J; Buteau J; Agrawal S; Ho B; Nguyen A; Liu V; Lee J; Woo H; Hsiao E; Sutherland T; Perry E; Stricker P; Hofman MS; Kasivisvanathan V; Roberts M; Murphy D, 2024, 'Beyond Prostate Imaging Reporting and Data System: Combining Magnetic Resonance Imaging Prostate Imaging Reporting and Data System and Prostate-Specific Membrane Antigen-Positron Emission Tomography/Computed Tomography PRIMARY Score in a Composite (P) Score for More Accurate Diagnosis of Clinically Significant Prostate Cancer', Journal of Urology, 212, pp. 299 - 307, http://dx.doi.org/10.1097/JU.0000000000004010

Buteau JP; Moon D; Fahey MT; Roberts MJ; Thompson J; Murphy DG; Papa N; Mitchell C; De Abreu Lourenco R; Dhillon HM; Kasivisvanathan V; Francis RJ; Stricker P; Agrawal S; O'Brien J; McVey A; Sharma G; Levy S; Ayati N; Nguyen A; Lee SF; Pattison DA; Sivaratnam D; Frydenberg M; Du Y; Titus J; Lee ST; Ischia J; Jack G; Hofman MS; Emmett L, 2024, 'Clinical Trial Protocol for PRIMARY2: A Multicentre, Phase 3, Randomised Controlled Trial Investigating the Additive Diagnostic Value of [⁶⁸Ga]Ga-PSMA-11 Positron Emission Tomography/Computed Tomography in Men with Negative or Equivocal Multiparametric Magnetic Resonance Imaging for the Diagnosis of Clinically Significant Prostate Cancer', European urology oncology, 7, pp. 544 - 552, http://dx.doi.org/10.1016/j.euo.2023.11.008

Geboers B; Meijer D; Counter W; Blazevski A; Thompson J; Doan P; Gondoputro W; Katelaris A; Haynes AM; Delprado W; O'Neill G; Yuen C; Vis AN; van Leeuwen PJ; Ho B; Liu V; Lee J; Donswijk ML; Oprea-Lager D; Scheltema MJ; Emmett L; Stricker PD, 2024, 'Prostate-specific membrane antigen positron emission tomography in addition to multiparametric magnetic resonance imaging and biopsies to select prostate cancer patients for focal therapy', BJU International, 133, pp. 14 - 22, http://dx.doi.org/10.1111/bju.16207

Geboers B; Scheltema MJ; Jung J; Bakker J; Timmer FEF; Cerutti X; Katelaris A; Doan P; Gondoputro W; Blazevski A; Agrawal S; Matthews J; Haynes AM; Robertson T; Thompson JE; Meijerink MR; Clark SJ; de Gruijl TD; Stricker PD, 2024, 'Irreversible electroporation of localised prostate cancer downregulates immune suppression and induces systemic anti-tumour T-cell activation – IRE-IMMUNO study', BJU International, http://dx.doi.org/10.1111/bju.16496

Emmett L; Papa N; Hope T; Fendler W; Calais J; Burger I; Eiber M; Barbato F; Moon D; Xue A; Franklin A; Thompson J; Rasiah K; Frydenberg M; Yaxley J; Buteau J; Liu V; Nguyen A; Hsiao E; Stricker P; Hofman M; Kasivisvanathan V; Roberts M; Murphy D, 2024, 'Combining MRI PI-RADS and PSMA-PET/CT PRIMARY score in a composite (P) score for more accurate diagnosis of clinically significant prostate cancer', European Urology, 85, pp. S476 - S476, http://dx.doi.org/10.1016/s0302-2838(24)00417-2

Doan P; Katelaris A; Scheltema MJ; Hayen A; Amin A; Siriwardana A; Tran M; Geboers B; Gondoputro W; Haynes AM; Matthews J; Delprado W; Stricker PD; Thompson J, 2023, 'The relationship between biochemical recurrence and number of lymph nodes removed during surgery for localized prostate cancer', BMC Urology, 23, http://dx.doi.org/10.1186/s12894-023-01228-3

Gondoputro W; Doan P; Katelaris A; Scheltema MJ; Geboers B; Agrawal S; Liu Z; Yaxley J; Savdie R; Rasiah K; Frydenberg M; Roberts MJ; Malouf D; Wong D; Shnier R; Delprado W; Emmett L; Stricker PD; Thompson J, 2023, '⁶⁸Ga-PSMA-PET/CT in addition to mpMRI in men undergoing biopsy during active surveillance for low- to intermediate-risk prostate cancer: study protocol for a prospective cross-sectional study', Translational Andrology and Urology, 12, pp. 1598 - 1606, http://dx.doi.org/10.21037/tau-22-708

Kelly BD; Ptasznik G; Roberts MJ; Doan P; Stricker P; Thompson J; Buteau J; Chen K; Alghazo O; O'Brien JS; Hofman MS; Frydenberg M; Lawrentschuk N; Lundon D; Murphy DG; Emmett L; Moon D, 2023, 'A Novel Risk Calculator Incorporating Clinical Parameters, Multiparametric Magnetic Resonance Imaging, and Prostate-Specific Membrane Antigen Positron Emission Tomography for Prostate Cancer Risk Stratification Before Transperineal Prostate Biopsy', European Urology Open Science, 53, pp. 90 - 97, http://dx.doi.org/10.1016/j.euros.2023.05.002

Best O; Canagasingham A; Liu Z; Doan P; Haynes AM; Delprado W; Maclean F; Yuen C; Stricker P; Thompson J, 2023, 'Index grade group is superior to composite grade group for prediction of biochemical recurrence following radical prostatectomy', Pathology, 55, pp. 492 - 497, http://dx.doi.org/10.1016/j.pathol.2022.10.012

Geboers B; Scheltema MJ; Blazevski A; Katelaris A; Doan P; Ali I; Agrawal S; Barreto D; Matthews J; Haynes AM; Delprado W; Shnier R; Thompson JE; Stricker PD, 2023, 'Median 4-year outcomes of salvage irreversible electroporation for localized radio-recurrent prostate cancer', BJU International, 131, pp. 14 - 22, http://dx.doi.org/10.1111/bju.15948

Scheltema MJ; Geboers B; Blazevski A; Doan P; Katelaris A; Agrawal S; Barreto D; Shnier R; Delprado W; Thompson JE; Stricker PD, 2023, 'Median 5-year outcomes of primary focal irreversible electroporation for localised prostate cancer', BJU International, 131, pp. 6 - 13, http://dx.doi.org/10.1111/bju.15946

Blazevski A; Geboers B; Scheltema MJ; Gondoputro W; Doan P; Katelaris A; Agrawal S; Baretto D; Matthews J; Haynes AM; Delprado W; Shnier R; van den Bos W; Thompson JE; Lawrentschuk N; Stricker PD, 2023, 'Salvage irreversible electroporation for radio-recurrent prostate cancer – the prospective FIRE trial', BJU International, 131, pp. 23 - 31, http://dx.doi.org/10.1111/bju.15947

Doan P; Counter W; Papa N; Sheehan-Dare G; Ho B; Lee J; Liu V; Thompson JE; Agrawal S; Roberts MJ; Buteau J; Hofman MS; Moon D; Lawrentschuk N; Murphy D; Stricker PD; Emmett L, 2023, 'Synchronous vs independent reading of prostate-specific membrane antigen positron emission tomography (PSMA-PET) and magnetic resonance imaging (MRI) to improve diagnosis of prostate cancer', BJU International, 131, pp. 588 - 595, http://dx.doi.org/10.1111/bju.15929

Katelaris A; Amin A; Blazevski A; Scheltema MJ; Cusick T; Farraha M; Barreto D; Haynes AM; Gondoputro W; Agrawal S; Stricker P; Thompson J, 2023, 'Outcomes for active surveillance are similar for men with favourable risk ISUP-2 to those with ISUP-1 prostate cancer: A pair matched cohort study', Journal of Clinical Urology, http://dx.doi.org/10.1177/20514158231154702

Buteau JP; Moon D; Fahey MT; Roberts M; Thompson J; Murphy DG; Papa N; Mitchell C; Kasivisvanathan V; Stricker P; O'Brien J; Counter W; Sharma G; Agrawal S; Ho B; Yeung T; De Abreu Lourenço R; Dhillon HM; Hofman MS; Emmett L, 2023, 'PRIMARY2: A phase III, multi-centre, randomised controlled trial investigating the additive diagnostic value of [⁶⁸Ga]Ga-PSMA-11 PET/CT in men with negative/equivocal MRI in the diagnosis of clinically significant prostate cancer.', Journal of Clinical Oncology, 41, pp. TPS397 - TPS397, http://dx.doi.org/10.1200/jco.2023.41.6_suppl.tps397

Scheltema MJV; Geboers B; Meijer D; Counter W; Thompson J; Doan P; Gondoputro W; Katelaris A; Haynes AM; Delprado W; Vis A; van Leeuwen P; Ho B; Liu V; Lee J; Donswijk M; Oprea-Lager D; Emmett L; Stricker P, 2023, 'The value of PSMA-PET in Addition to mpMRI and Systematic Biopsies to Select Patients for Hemi-ablative Focal Therapy in Prostate Cancer', European Urology Open Science, 57, pp. S45 - S45, http://dx.doi.org/10.1016/s2666-1683(23)01325-3

de Silva S; Lockhart KR; Aslan P; Nash P; Hutton A; Malouf D; Lee D; Cozzi P; MacLean F; Thompson J, 2022, 'Differentiation of renal masses with multi-parametric MRI: the de Silva St George classification scheme', BMC Urology, 22, http://dx.doi.org/10.1186/s12894-022-01082-9

Blazevski A; Gondoputro W; Scheltema MJ; Amin A; Geboers B; Barreto D; Haynes AM; Shnier R; Delprado W; Agrawal S; Thompson JE; Stricker PD, 2022, 'Salvage robot-assisted radical prostatectomy following focal ablation with irreversible electroporation: feasibility, oncological and functional outcomes', BMC Urology, 22, http://dx.doi.org/10.1186/s12894-022-00978-w

Geboers B; Gondoputro W; Thompson JE; Reesink DJ; van Riel LAMJG; Zhang D; Blazevski A; Doan P; Agrawal S; Matthews J; Haynes AM; Liu Z; Delprado W; Shnier R; de Reijke TM; Lawrentschuk N; Stijns PEF; Yaxley JW; Scheltema MJ; Stricker PD, 2022, 'Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging to Detect Residual Prostate Cancer Following Irreversible Electroporation—A Multicenter Validation Study', European Urology Focus, 8, pp. 1591 - 1598, http://dx.doi.org/10.1016/j.euf.2022.04.010

Doan P; Scheltema MJ; Amin A; Shnier R; Geboers B; Gondoputro W; Moses D; van Leeuwen PJ; Haynes AM; Matthews J; Brenner P; O’Neill G; Yuen C; Delprado W; Stricker P; Thompson J, 2022, 'Final Analysis of the Magnetic Resonance Imaging in Active Surveillance Trial', Journal of Urology, 208, pp. 1028 - 1036, http://dx.doi.org/10.1097/JU.0000000000002885

Ptasznik G; Papa N; Kelly BD; Thompson J; Stricker P; Roberts MJ; Hofman MS; Buteau J; Murphy DG; Emmett L; Moon D, 2022, 'High prostate-specific membrane antigen (PSMA) positron emission tomography (PET) maximum standardized uptake value in men with PI-RADS score 4 or 5 confers a high probability of significant prostate cancer', BJU International, 130, pp. 5 - 7, http://dx.doi.org/10.1111/bju.15736

Emmett L; Papa N; Buteau J; Ho B; Liu V; Roberts M; Thompson J; Moon D; Sheehan-Dare G; Alghazo O; Agrawal S; Murphy D; Stricker P; Hope TA; Hofman MS, 2022, 'The PRIMARY Score: Using Intraprostatic ⁶⁸Ga-PSMA PET/CT Patterns to Optimize Prostate Cancer Diagnosis', Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 63, pp. 1644 - 1650, http://dx.doi.org/10.2967/jnumed.121.263448

Lee N; Canagasingham A; Bajaj M; Shanmugasundaram R; Hutton A; Bucci J; Graham P; Thompson J; Ni J, 2022, 'Urine exosomes as biomarkers in bladder cancer diagnosis and prognosis: From functional roles to clinical significance', Frontiers in Oncology, 12, http://dx.doi.org/10.3389/fonc.2022.1019391

Doan P; Scheltema MJ; Amin A; Shnier R; Geboers B; Gondoputro W; Moses D; van Leeuwen PJ; Haynes AM; Matthews J; Brenner P; O'Neill G; Yuen C; Delprado W; Stricker P; Thompson J, 2022, 'Reply by Authors.', Investigative Urology, pp. 101097ju000000000000288502 - 101097ju000000000000288502, http://dx.doi.org/10.1097/ju.0000000000002885.02

Katelaris DA; Gibson DD; Nalavenkata DS; Thompson DJ, 2022, 'Robotic Salvage Seminal Vesiculectomy for radio-recurrent prostate cancer post LDR brachytherapy following multiple negative trans-perineal biopsies', Urology Case Reports, 43, http://dx.doi.org/10.1016/j.eucr.2022.102064

Gondoputro W; Thompson J; Evans M; Bolton D; Frydenberg M; Murphy DG; Haynes AM; Agrawal S; Stricker P; Papa N, 2022, 'How Does Age Affect Urinary Continence following Robot-Assisted Radical Prostatectomy? A Prospective Multi-Institutional Study Using Independently Collected, Validated Questionnaires', Journal of Urology, 207, pp. 1048 - 1056, http://dx.doi.org/10.1097/JU.0000000000002391

Gondoputro W; Scheltema MJ; Blazevski A; Doan P; Thompson JE; Amin A; Geboers B; Agrawal S; Siriwardana A; Van Leeuwen PJ; van Oosterom MN; Van Leeuwen FWB; Emmett L; Stricker PD, 2022, 'Robot-Assisted Prostate-Specific Membrane Antigen-Radioguided Surgery in Primary Diagnosed Prostate Cancer', Journal of Nuclear Medicine, 63, pp. 1659 - 1664, http://dx.doi.org/10.2967/JNUMED.121.263743

Katelaris A; De Silva S; Thompson DJ, 2022, 'The evolving role of multi-parametric MRI in the evaluation of bladder cancer: Revealing what lies beneath the surface', Urology Case Reports, 40, http://dx.doi.org/10.1016/j.eucr.2021.101906

Emmett L; Buteau J; Papa N; Moon D; Thompson J; Roberts MJ; Rasiah K; Pattison DA; Yaxley J; Thomas P; Hutton AC; Agrawal S; Amin A; Blazevski A; Chalasani V; Ho B; Nguyen A; Liu V; Lee J; Sheehan-Dare G; Kooner R; Coughlin G; Chan L; Cusick T; Namdarian B; Kapoor J; Alghazo O; Woo HH; Lawrentschuk N; Murphy D; Hofman MS; Stricker P, 2021, 'The Additive Diagnostic Value of Prostate-specific Membrane Antigen Positron Emission Tomography Computed Tomography to Multiparametric Magnetic Resonance Imaging Triage in the Diagnosis of Prostate Cancer (PRIMARY): A Prospective Multicentre Study[Formula presented]', European Urology, 80, pp. 682 - 689, http://dx.doi.org/10.1016/j.eururo.2021.08.002

de Silva S; Lockhart KR; Aslan P; Nash P; Hutton A; Malouf D; Lee D; Cozzi P; MacLean F; Thompson J, 2021, 'The diagnostic utility of diffusion weighted MRI imaging and ADC ratio to distinguish benign from malignant renal masses: sorting the kittens from the tigers', BMC Urology, 21, http://dx.doi.org/10.1186/s12894-021-00832-5

Blazevski A; Gondoputro W; Scheltema MJ; Amin A; Geboers B; Barreto D; Haynes A-M; Shnier R; Delprado W; Agrawal S; Thompson JE; Stricker P, 2021, 'Salvage Robot-assisted Radical Prostatectomy Following Focal Ablation With Irreversible Electroporation: Feasibility, Oncological and Functional Outcomes', , http://dx.doi.org/10.21203/rs.3.rs-1027405/v1

Gondoputro W; Thompson J; Frydenberg M; Murphy DG; Bolton D; Stricker P; Papa N, 2021, 'Does age affect continence outcomes following robot-assisted radical prostatectomy? Results from an Australian multi-institutional study', EUROPEAN UROLOGY, 79, pp. S1626 - S1626, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000674144301424&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Blazevski A; Amin A; Scheltema MJ; Balakrishnan A; Haynes AM; Barreto D; Cusick T; Thompson J; Stricker PD, 2021, 'Focal ablation of apical prostate cancer lesions with irreversible electroporation (IRE)', World Journal of Urology, 39, pp. 1107 - 1114, http://dx.doi.org/10.1007/s00345-020-03275-z

Gondoputro W; Blazevski A; Amin A; Scheltema M; Agrawal S; Cusick T; Van Leeuwen P; Van Leeuwen F; Emmett L; Thompson J; Stricker P, 2021, 'MP50-05 INTERIM RESULTS FROM THE DETECT TRIAL: A PROSPECTIVE CLINICAL TRIAL EVALUATING ^99M TC-LABELLED PSMA RADIOGUIDED SURGERY TO AID THE INTRAOPERATIVE DETECTION OF LYMPH NODE METASTASES DURING ROBOT-ASSISTED RADICAL PROSTATECTOMY AND EXTENDED PELVIC LYMPH NODE DISSECTION FOR PROSTATE CANCER', Journal of Urology, 206, http://dx.doi.org/10.1097/ju.0000000000002076.05

de Silva S; Lockhart K; Aslan P; Nash P; Hutton A; Malouf D; Lee D; Cozzi P; Maclean F; Thompson J, 2020, 'Chemical shift imaging in the identification of those renal tumours that contain microscopic fat and the utility of multiparametric MRI in their differentiation', Journal of Medical Imaging and Radiation Oncology, 64, pp. 762 - 768, http://dx.doi.org/10.1111/1754-9485.13082

Thompson J; Amin A; Stricker P, 2020, 'Magnetic Resonance Imaging Improves Selection for Active Surveillance and Can Extend the Interval Between Biopsies', European Urology, 78, pp. 518 - 519, http://dx.doi.org/10.1016/j.eururo.2020.07.001

Amin A; Scheltema MJ; Shnier R; Blazevski A; Moses D; Cusick T; Siriwardena A; Yuen B; Van Leeuwen PJ; Haynes AM; Matthews J; Brenner P; O'Neill G; Yuen C; Delprado W; Stricker P; Thompson J; Montorsi F; Gandaglia G; Fossati N; Briganti A, 2020, 'Re: The Magnetic Resonance Imaging in Active Surveillance (MRIAS) Trial: Use of Baseline Multiparametric Magnetic Resonance Imaging and Saturation Biopsy to Reduce the Frequency of Surveillance Prostate Biopsies', Journal of Urology, 204, pp. 843, http://dx.doi.org/10.1097/JU.0000000000001190

, 2020, 'Reply by Authors', Journal of Urology, 204, pp. 843 - 844, http://dx.doi.org/10.1097/JU.0000000000001191

Thompson JE; Stricker PD, 2020, 'Editorial Comment', Journal of Urology, 204, pp. 495, http://dx.doi.org/10.1097/JU.0000000000000811.01

Algohary A; Shiradkar R; Pahwa S; Purysko A; Verma S; Moses D; Shnier R; Haynes AM; Delprado W; Thompson J; Tirumani S; Mahran A; Rastinehad AR; Ponsky L; Stricker PD; Madabhushi A, 2020, 'Combination of peri-tumoral and intra-tumoral radiomic features on bi-parametric mri accurately stratifies prostate cancer risk: A multi-site study', Cancers, 12, pp. 1 - 14, http://dx.doi.org/10.3390/cancers12082200

Thompson JE; Sridhar AN; Shaw G; Shaw G; Rajan P; Mohammed A; Briggs TP; Nathan S; Kelly JD; Sooriakumaran P, 2020, 'Peri-operative, functional and early oncologic outcomes of salvage robotic-assisted radical prostatectomy after high-intensity focused ultrasound partial ablation', BMC Urology, 20, http://dx.doi.org/10.1186/s12894-020-00656-9

Blazevski A; Scheltema MJ; Yuen B; Masand N; Nguyen TV; Delprado W; Shnier R; Haynes AM; Cusick T; Thompson J; Stricker P, 2020, 'Oncological and Quality-of-life Outcomes Following Focal Irreversible Electroporation as Primary Treatment for Localised Prostate Cancer: A Biopsy-monitored Prospective Cohort', European urology oncology, 3, pp. 283 - 290, http://dx.doi.org/10.1016/j.euo.2019.04.008

Amin A; Scheltema MJ; Shnier R; Blazevski A; Moses D; Cusick T; Siriwardena A; Yuen B; Van Leeuwen PJ; Haynes AM; Matthews J; Brenner P; O'Neill G; Yuen C; Delprado W; Stricker P; Thompson J, 2020, 'The Magnetic Resonance Imaging in Active Surveillance (MRIAS) Trial: Use of Baseline Multiparametric Magnetic Resonance Imaging and Saturation Biopsy to Reduce the Frequency of Surveillance Prostate Biopsies', Journal of Urology, 203, pp. 910 - 917, http://dx.doi.org/10.1097/JU.0000000000000693

Amin A; Blazevski A; Thompson J; Scheltema MJ; Hofman MS; Murphy D; Lawrentschuk N; Sathianathen N; Kapoor J; Woo HH; Chalasani V; Rasiah K; van Leeuwen PJ; Tang R; Cusick T; Stricker P; Emmett L, 2020, 'Protocol for the PRIMARY clinical trial, a prospective, multicentre, cross-sectional study of the additive diagnostic value of gallium-68 prostate-specific membrane antigen positron-emission tomography/computed tomography to multiparametric magnetic resonance imaging in the diagnostic setting for men being investigated for prostate cancer', BJU International, 125, pp. 515 - 524, http://dx.doi.org/10.1111/bju.14999

Wang J; Ni J; Beretov J; Thompson J; Graham P; Li Y, 2020, 'Exosomal microRNAs as liquid biopsy biomarkers in prostate cancer', Critical Reviews in Oncology/Hematology, 145, http://dx.doi.org/10.1016/j.critrevonc.2019.102860

Pang B; Zhu Y; Ni J; Thompson J; Malouf D; Bucci J; Graham P; Li Y, 2020, 'Extracellular vesicles: The next generation of biomarkers for liquid biopsy-based prostate cancer diagnosis', Theranostics, 10, pp. 2309 - 2326, http://dx.doi.org/10.7150/thno.39486

Pang B; Zhu Y; Ni J; Ruan J; Thompson J; Malouf D; Bucci J; Graham P; Li Y, 2020, 'Quality assessment and comparison of plasma-derived extracellular vesicles separated by three commercial kits for prostate cancer diagnosis', International Journal of Nanomedicine, 15, pp. 10241 - 10256, http://dx.doi.org/10.2147/IJN.S283106

Scheltema MJ; Chang JI; Stricker PD; van Leeuwen PJ; Nguyen QA; Ho B; Delprado W; Lee J; Thompson JE; Cusick T; Spriensma AS; Siriwardana AR; Yuen C; Kooner R; Hruby G; O'Neill G; Emmett L, 2019, 'Diagnostic accuracy of ⁶⁸Ga-prostate-specific membrane antigen (PSMA) positron-emission tomography (PET) and multiparametric (mp)MRI to detect intermediate-grade intra-prostatic prostate cancer using whole-mount pathology: impact of the addition of ⁶⁸Ga-PSMA PET to mpMRI', BJU International, 124, pp. 42 - 49, http://dx.doi.org/10.1111/bju.14794

Back to profile page